Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
168.20    -2.20 (-1.29%)
Bid:
167.60
Ask:
168.60
Spread: 1.00 (0.597%)
Market Cap: £206.41m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Director Declaration

19 Jun 2025 14:30

RNS Number : 6276N
SThree plc
19 June 2025
 

19 June 2025

 

 

SThree plc

 

(the "Company")

 

Appointment of Senior Independent Director and changes in Directors' Responsibilities

 

As previously announced on 24 January 2025, having served as a non-executive director for nineyears, Denise Collis will be retiring from the Board on 30 June 2025.

In accordance with UKLR 6.4.6, SThree plc, the global STEM workforce consultancy, todayannounces that, with effect from 1 July 2025, Imogen Joss, who was appointed to the Board in December 2022, will become Senior Independent Director and Chair of the Remuneration Committee and Sanjeevan Bala, who was appointed to the Board in April 2024, will become Employee Engagement NED.

James Bilefield, Chair, said:

"I am immensely grateful to Denise for her significant contribution and dedication since her appointment. In addition to successfully discharging her responsibilities as our Senior Independent Director and Remuneration Committee Chair, Denise fully embraced the role of being our first Employee Engagement NED and has been a champion of and mentor to many of our colleagues in the business. I look forward to working with Imogen and Sanjeevan in their new roles."

 

 

Enquiries:

 

 

 

SThree plc

Timo Lehne, CEO

Andrew Beach, CFO

Keren Oser, Investor Relations Director

 

 

 via Alma

Alma Strategic Communications

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Will Ellis Hancock

SThree@almastrategic.com

 

 

 

Notes to editors

SThree plc brings skilled people together to build the future. We are the global STEM workforce consultancy, placing highly skilled, STEM specialist workers in the industries where they are needed most. We advise businesses, build expert teams, and deliver project solutions for our clients. With more than 38 years of experience in pure-play STEM and a global team with local expertise across 11 countries, we cover high-demand skills across Engineering, Life Sciences and Technology roles.

 

We provide permanent and flexible contract talent to a diverse base of around 6,000 clients. By combining advanced technology with expertise, we push beyond traditional boundaries to deliver tailored solutions, leveraging data and insight from our world-class operating platform.

 

Outpace tomorrow, together

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNFLMJTMTMBBRA
Date   Source Headline
2nd Mar 202611:15 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 202612:15 pmRNSDirector/PDMR Shareholding
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSCommencement of Share Buyback Programme
2nd Feb 20261:24 pmRNSTotal Voting Rights
27th Jan 20267:00 amRNSFY25 Final Results
13th Jan 20269:08 amRNSDirector/PDMR Shareholding
2nd Jan 202611:56 amRNSTotal Voting Rights
2nd Jan 202611:45 amRNSPurchase of shares into the EBT
2nd Jan 202610:56 amRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSFY25 Full Year Trading Update
15th Dec 20252:11 pmRNSHolding(s) in Company
15th Dec 202510:14 amRNSDirector/PDMR Shareholding
11th Dec 20254:28 pmRNSHolding(s) in Company
9th Dec 20255:35 pmRNSHolding(s) in Company
1st Dec 202512:14 pmRNSTotal Voting Rights
26th Nov 20258:00 amRNSDirector Declaration
26th Nov 20257:00 amRNSDirectorate change
13th Nov 20253:40 pmRNSDirector/PDMR Shareholding
7th Nov 20253:57 pmRNSHolding(s) in Company
31st Oct 202511:42 amRNSTotal Voting Rights
24th Oct 20259:37 amRNSHolding(s) in Company
22nd Oct 20251:03 pmRNSHolding(s) in Company
14th Oct 20254:28 pmRNSDirector/PDMR Shareholding
6th Oct 202511:04 amRNSDirector Declaration
1st Oct 202512:09 pmRNSResult of Meeting
30th Sep 202512:48 pmRNSTotal Voting Rights
26th Sep 202510:41 amRNSHolding(s) in Company
17th Sep 20259:30 amRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSFY25 Q3 Trading Update
15th Sep 202511:00 amRNSDirector/PDMR Shareholding
10th Sep 20251:59 pmRNSHolding(s) in Company
10th Sep 202510:45 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of GM
1st Sep 202511:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.